Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The FEBS Journal|December 12, 2018
Previously uncharacterized amino acid residues in histone H3 and H4 mutants with roles in DNA damage repair response and cellular agingPilendra K Thakre, Athira Sv, Upendarrao Golla, et al.
Dalton Transactions (Cambridge, England : 2003)|July 6, 2016
Synthesis, structure, magnetic and biological activity studies of bis-hydrazone derived Cu(ii) and Co(ii) coordination compoundsUpendarrao Golla, Amit Adhikary, Amit Kumar Mondal, et al.
Cancers|October 26, 2024
From Deworming to Cancer Therapy: Benzimidazoles in Hematological MalignanciesUpendarrao Golla, Satyam Patel, Nyah Shah, et al.
The FEBS Journal|October 9, 2016
Sen1, the homolog of human Senataxin, is critical for cell survival through regulation of redox homeostasis, mitochondrial function, and the TOR pathway in Saccharomyces cerevisiaeSanthosh Kumar Sariki, Pushpendra Kumar Sahu, Upendarrao Golla, et al.
Plos One|June 7, 2013
Sen1p contributes to genomic integrity by regulating expression of ribonucleotide reductase 1 (RNR1) in Saccharomyces cerevisiaeUpendarrao Golla, Vikash Singh, Gajendra Kumar Azad, et al.
FEBS Open Bio|February 4, 2014
Ebselen induces reactive oxygen species (ROS)-mediated cytotoxicity in Saccharomyces cerevisiae with inhibition of glutamate dehydrogenase being a targetGajendra Kumar Azad, Vikash Singh, Papita Mandal, et al.
Current Pharmaceutical Biotechnology|October 14, 2020
Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A ReviewRout George Kerry, Gitishree Das, Upendarrao Golla, et al.
Non-Coding RNA|March 22, 2022
ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human MalignanciesUpendarrao Golla, Kishore Sesham, Siva Dallavalasa, et al.
International Journal of Molecular Sciences|July 27, 2022
Therapeutic Benefits of Selenium in Hematological MalignanciesMelanie A Ehudin, Upendarrao Golla, Devnah Trivedi, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK KinasesVijay Pralhad Kale, Jeremy A Hengst, Arati K Sharma, et al.
Pageof 3